Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet Journal Article


Authors: Armstrong, A. J.; Antonarakis, E. S.; Taplin, M. E.; Kelly, W. K.; Beltran, H.; Fizazi, K.; Dahut, W. L.; Shore, N.; Slovin, S.; George, D.; Carducci, M. A.; Corn, P.; Danila, D.; Dreicer, R.; Heath, E.; Rathkopf, D.; Liu, G.; Nanus, D.; Stein, M.; Smith, M. R.; Sternberg, C.; Wilding, G.; Nelson, P. S.; Halabi, S.; Kantoff, P.; Clarke, N. W.; Evans, C. P.; Heidenreich, A.; Mottet, N.; Gleave, M.; Morris, M. J.; Scher, H. I.
Article Title: Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet
Keywords: cancer patient; homologous recombination; editorial; prostate cancer; patient care; nomenclature; testosterone blood level; testosterone; personalized medicine; castration resistant prostate cancer; human; priority journal; medical terminology
Journal Title: Annals of Oncology
Volume: 29
Issue: 1
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-01-01
Start Page: 23
End Page: 25
Language: English
DOI: 10.1093/annonc/mdx648
PROVIDER: scopus
PUBMED: 29088323
PMCID: PMC6248721
DOI/URL:
Notes: Editorial -- Export Date: 1 March 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Susan Slovin
    254 Slovin
  2. Michael Morris
    580 Morris
  3. Dana Elizabeth Rathkopf
    274 Rathkopf
  4. Howard Scher
    1130 Scher
  5. Daniel C Danila
    155 Danila
  6. Philip Wayne Kantoff
    198 Kantoff
Related MSK Work